Anaes SAQs · TIVA & target-controlled infusion
The clinical applications of the TIVA
Final SAQ — the ERAS/fast-track; the HPV preservation (the thoracic); the PONV reduction (25%); the OFA; the middle-ear; the QT; the awareness risk (the NAP5 — the higher).
On this page
Study tools
Target exams
ANZCAFRCAABAEDAIC
Prompt
Discuss the clinical indications for the TIVA and the evidence for its advantages over the volatile anaesthesia.
Question
Discuss the clinical indications for the TIVA and the evidence for its advantages over the volatile anaesthesia. (Question stem restated — the worked answers below carry the primary-source citations.)
References2ShowHide
- [1]Keresztes M, et al. Target-Controlled Infusion for Caesarean Delivery Under General Anesthesia: From Conventional Pharmacokinetic Models to Physiologically Based Pharmacokinetic Modeling. Life, 2026.PMID 42195295
- [3]Tsai YF, et al. Dexmedetomidine Dosing Strategies in Sedation and Anesthesia: Pharmacokinetics, Safety, and Clinical Applications - A Narrative Review. Drug Des Devel Ther, 2026.PMID 42232093